Zoetis receives european commission marketing authorization for portela® (relfovetmab) to alleviate pain associated with osteoarthritis in cats

Parsippany, n.j.--(business wire)---- $zts #animalhealth--portela becomes first mab therapy with a three-month dosing interval approved for the alleviation of pain associated with oa in cats.

ZTS Ratings Summary

ZTS Quant Ranking